default author photo

Thomas Bengtsson

StatMind

Lund

Sweden

SCHOLARLY PAPERS

2

DOWNLOADS

922

TOTAL CITATIONS

1

Scholarly Papers (2)

1.

Inhaled Budesonide in the Treatment of Early COVID-19 Illness: A Randomised Controlled Trial

Number of pages: 25 Posted: 08 Feb 2021
University of Oxford - Nuffield Department of Clinical Medicine, University of Oxford - Nuffield Department of Clinical Medicine, University of Oxford - Nuffield Department of Clinical Medicine, University of Oxford - Nuffield Department of Clinical Medicine, University of Oxford - Nuffield Department of Clinical Medicine, University of Oxford - Nuffield Department of Clinical Medicine, University of Oxford - Nuffield Department of Clinical Medicine, Eynsham Medical Group, White Horse Medical Practice, Windrush Medical Practice, University of Oxford - Nuffield Department of Primary Care Health Sciences, University of Oxford - Nuffield Department of Clinical Medicine, University of Oxford - Nuffield Department of Clinical Medicine, University of Oxford - Nuffield Department of Medicine, Imperial College London - National Heart and Lung Institute (NHLI), University of Newcastle (Australia) - Priority Research Centre for Healthy Lungs, Imperial College London - National Heart and Lung Institute (NHLI), University of Nottingham, StatMind, StatMind, Imperial College London - National Heart and Lung Institute (NHLI), University of Oxford - Nuffield Department of Clinical Medicine and University of Oxford - Respiratory Medicine Unit
Downloads 852 (70,639)
Citation 1

Abstract:

Loading...

2.

Seven Days Treatment With the Angiotensin II Type 2 Receptor Agonist C21 in Hospitalized COVID-19 Patients: A Placebo-Controlled Randomized Phase 2 Trial

Number of pages: 30 Posted: 23 Jul 2021
Karolinska Institutet, Vicore Pharma AB, University College London - Centre for inflammation and Tissue Repair, University College London, StatMind, B.J. Medical College, Asarwa, Noble Hospitals Pvt. Ltd, Hadapsar - Department of Medicine, Uppsala University, Vicore Pharma AB, Vicore Pharma AB, Vicore Pharma AB and Karolinska Institutet
Downloads 70 (875,328)

Abstract:

Loading...